Bio

Specialties:

  • oncology

Affiliation:

  • Professor of Medicine and Engineering, University of Southern California Keck School of Medicine and Viterbi School of Engineering

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Oncology:

    MONDAY, July 28, 2014 (HealthDay News) -- Approved use for Imbruvica (ibrutinib) has been expanded to include people with chronic lymphocytic leukemia (CLL) who have a deletion in chromosome 17, the U.S. Food and Drug Administration said Monday in a news release.

    People with the 17p dele...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    FRIDAY, July 25, 2014 (HealthDay News) -- Although cervical cancers are declining in the United States and Canada, other cancers linked to human papillomavirus (HPV) are increasing, a new study indicates.

    HPV-related cancers of the anus and the base of the tongue and tonsils have increase...Full Article

  • Sharecare News
    Sharecare News posted a story about Transplantation Medicine:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Most blood cancer patients in the United States who need a bone marrow transplant can find an acceptable match through the National Marrow Donor Program, a new study has determined.

    Depending on a patient's race or ethnic background, the study ...Full Article

  • Sharecare News
    Sharecare News posted a story about Hematology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL), the

    ...Full Article
  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Painful or itchy skin lesions could be a warning sign of skin cancer, researchers report.

    "Patients sometimes have multiple lesions that are suspicious looking, and those that are itchy or painful should raise high concerns for non-melanoma ski...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, July 18, 2014 (HealthDay News) -- A new study involving data on more than 1 million women finds the HPV test outperforming the standard Pap test in assessing cervical cancer risk.

    Researchers at the U.S. National Cancer Institute (NCI) conclude that a negative test for HPV (human ...Full Article

  • Sharecare News
    Sharecare News posted a story about Urology:

    FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer patients are more likely to be diagnosed with aggressive disease, receive less effective treatment and die sooner if they also have depression, a new study suggests.

    Researchers analyzed data from more than 41,200 American men who ...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, July 9, 2014 (HealthDay News) -- The drug exemestane worked slightly better than the drug tamoxifen at preventing a recurrence of breast cancer in certain premenopausal women, according to a new study.

    Almost 93 percent of women on exemestane (Aromasin) remained free of breast ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, July 3, 2014 (HealthDay News) -- Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

    Some 70,800 Americans will be diagnosed w...Full Article

  • Sharecare News
    Sharecare News posted a story about Hepatology:

    TUESDAY, July 1, 2014 (HealthDay News) -- Although it looked promising in early studies, the drug everolimus didn't improve survival for people with advanced liver cancer in its latest trial, a new study found.

    The findings from the phase 3 clinical trial are disappointing because earlie...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, July 1, 2014 (HealthDay News) -- While medications are helping HIV-positive people avoid developing full-blown AIDS indefinitely, a new study finds that cancer patients with HIV are up to four times less likely to be treated for their tumors.

    The research comes with caveats. It l...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, June 26, 2014 (HealthDay News) -- People who take low-dose aspirin for more than 10 years might be reducing their risk for pancreatic cancer, a new study suggests.

    Even taking a daily aspirin for just three years lowered the chances of the deadly cancer by 48 percent, the resear...Full Article

  • Sharecare News
    Sharecare News posted a story about Public Health:

    TUESDAY, June 24, 2014 (HealthDay News) -- Amanda, a 30-year-old who smoked during her pregnancy, wants people to know how important it is to keep trying to quit the dangerous habit.

    Her baby was born two months early, and spent weeks in an incubator.

    "She wasn't born with the ref...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, June 24, 2014 (HealthDay News) -- A diet rich in dairy products may slightly extend the lives of people diagnosed with colon cancer, a new study suggests.

    But at least one cancer doctor not involved with the study was skeptical of the research and its conclusions.

    The stu...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    MONDAY, June 23, 2014 (HealthDay News) -- Women with breast cancer who test positive for gene mutations linked with breast and ovarian cancer are more likely than those without the mutations to choose more extensive surgery, a new study finds.

    Genetic testing is recommended before surgery...Full Article